RCT for the Chinese Medicine in Treating Hypercholesterolemia

Summary

This is a randomized, double-blind, placebo-controlled clinical trial. Eligible subjects will randomized into a treatment group or placebo group. They will receive either Chinese medicine granules or placebo granules for 8 weeks followed by a 4-week observation period. The primary outcome would be the percent change in Low-density lipoprotein cholesterol levels (LDL-C) after treatment.

Timeline

Start

2025-01

Primary completion

2026-12

Completion

2027-04

Drugs

Indications